Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcomeJuan María Roldán‐Romero, Cristina Rodríguez‐Antona, Luis J. Leandro‐García et al.|Modern Pathology|2020Cited by 56
Biallelic <i>TSC2</i> Mutations in a Patient With Chromophobe Renal Cell Carcinoma Showing Extraordinary Response to TemsirolimusPablo Maroto, Cristina Rodríguez‐Antona, Geòrgia Anguera et al.|Journal of the National Comprehensive Cancer Network|2018Cited by 22
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinomaMaría Santos, Cristina Rodríguez‐Antona, Javier Lanillos et al.|Genetics in Medicine|2021Cited by 22
Deubiquitinase <scp>USP9X</scp> loss sensitizes renal cancer cells to <scp>mTOR</scp> inhibitionJuan María Roldán‐Romero, Cristina Rodríguez‐Antona, Carlos Valdivia et al.|International Journal of Cancer|2023Cited by 18
Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO studyJavier Trujillo‐Santos, Rosa López, Ignacio Escobar et al.|The Oncologist|2024Cited by 1